164 related articles for article (PubMed ID: 2423994)
1. [Early results of the treatment of Hodgkin's disease with alternating use in the CVPP and ABVD protocol].
Gabryś K; Kotlarek-Haus S; Sciborski R
Pol Tyg Lek; 1986 Feb; 41(7):195-8. PubMed ID: 2423994
[No Abstract] [Full Text] [Related]
2. [Treatment of Hodgkin's disease with alternately used drug combinations CVPP/ABVD].
Gabryś K; Sciborski R; Kotlarek-Haus S
Przegl Lek; 1988; 45(10):717-20. PubMed ID: 2469104
[No Abstract] [Full Text] [Related]
3. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
4. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
5. [Rescue treatment in Hodgkin's disease].
Zori Comba A; Koziner B
Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
[No Abstract] [Full Text] [Related]
6. [Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
Cervantes F; Reverter JC; Bladé J; Montserrat E; Rozman C
Sangre (Barc); 1988 Jun; 33(3):184-7. PubMed ID: 2459787
[No Abstract] [Full Text] [Related]
7. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
[No Abstract] [Full Text] [Related]
8. [Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].
Herold M; Anger G; Höche D; Kästner R
Med Klin (Munich); 1987 May; 82(10):345-9. PubMed ID: 2439886
[No Abstract] [Full Text] [Related]
9. Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
Donaldson SS; Link MP; McDougall IR; Parker BR; Shochat SJ
Cancer Treat Res; 1989; 41():307-15. PubMed ID: 2484294
[No Abstract] [Full Text] [Related]
10. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Constine LS
J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
[No Abstract] [Full Text] [Related]
11. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
12. Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
Canellos GP
Leukemia; 1996 Jun; 10 Suppl 2():s68. PubMed ID: 8649055
[No Abstract] [Full Text] [Related]
13. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
[TBL] [Abstract][Full Text] [Related]
14. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
15. [Results of the treatment of lymphogranulomatosis].
Kholin AV
Ter Arkh; 1986; 58(2):143-7. PubMed ID: 2422774
[No Abstract] [Full Text] [Related]
16. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
Tsushita K; Utsumi M; Shimoyama M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
[TBL] [Abstract][Full Text] [Related]
17. MOPP, ABVD, or both to treat Hodgkin's disease.
Martino R; Nomdedeu J; Brunet S
N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
[No Abstract] [Full Text] [Related]
18. [The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Zittoun R; Eghbali H; Audebert A; Rojouan J; David B; Blanc CM; Hoerni B; Debray J
Bull Cancer; 1987; 74(2):151-7. PubMed ID: 2440504
[TBL] [Abstract][Full Text] [Related]
19. Alternating drug combinations for advanced Hodgkin's disease.
N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
[No Abstract] [Full Text] [Related]
20. Treatment of advanced Hodgkin's disease.
Straus DJ
Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
